{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:40:29Z","timestamp":1790836829135,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jhepr.2022.100461","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T19:03:35Z","timestamp":1645556615000},"page":"100461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-7220","authenticated-orcid":false,"given":"Carla","family":"Osiowy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0458-5395","authenticated-orcid":false,"given":"Ken","family":"Swidinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Haylock-Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Sadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2687-940X","authenticated-orcid":false,"given":"Gerald Y.","family":"Minuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Doucette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-4116","authenticated-orcid":false,"given":"Philip","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8306-3968","authenticated-orcid":false,"given":"Edward","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alnoor","family":"Ramji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2587-1788","authenticated-orcid":false,"given":"Mang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7262-7713","authenticated-orcid":false,"given":"Carmine","family":"Nudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1472-0901","authenticated-orcid":false,"given":"Carla S.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2022.100461_bib1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/liv.14729","article-title":"The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappraisal","volume":"41","author":"Rizzetto","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100461_bib2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.14309\/ajg.0000000000000954","article-title":"Risk factors for Delta hepatitis in a North American cohort: who should be screened?","volume":"116","author":"Da","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2022.100461_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2020.02.030","article-title":"Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"73","author":"Alfaiate","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100461_bib4","doi-asserted-by":"crossref","first-page":"a021550","DOI":"10.1101\/cshperspect.a021550","article-title":"Hepatitis D virus coinfection and superinfection","volume":"4","author":"Negro","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jhepr.2022.100461_bib5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cld.2019.04.005","article-title":"HBV\/HDV coinfection: a challenge for therapeutics","volume":"23","author":"Koh","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2022.100461_bib6","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2020-323888","article-title":"Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease","volume":"70","author":"Urban","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2022.100461_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.gtc.2020.01.001","article-title":"Global epidemiology of viral hepatitis","volume":"49","author":"Razavi","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jhepr.2022.100461_bib8","series-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections","year":"2021"},{"key":"10.1016\/j.jhepr.2022.100461_bib9","first-page":"203","article-title":"Hepatitis delta virus epidemiology in the industrialized world","volume":"22","author":"Toy","year":"2020","journal-title":"AIDS Rev"},{"key":"10.1016\/j.jhepr.2022.100461_bib10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.gtc.2020.01.004","article-title":"Hepatitis delta: prevalence, natural history, and treatment options","volume":"49","author":"Hercun","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.jhepr.2022.100461_bib11","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.29574","article-title":"Genetic diversity and worldwide distribution of the deltavirus genus: a study of 2,152 clinical strains","volume":"66","author":"Le Gal","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100461_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/liv.14833","article-title":"Is hepatitis delta underestimated?","volume":"41","author":"Papatheodoridi","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100461_bib13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jhep.2021.01.014","article-title":"The changing context of hepatitis D","volume":"74","author":"Rizzetto","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100461_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100461_bib15","series-title":"Report on hepatitis B and C in Canada: 2017","year":"2019"},{"key":"10.1016\/j.jhepr.2022.100461_bib16","doi-asserted-by":"crossref","first-page":"E610","DOI":"10.9778\/cmajo.20190103","article-title":"Epidemiologic and clinical features of chronic hepatitis B virus infection in 8 Canadian provinces: a descriptive study by the Canadian HBV network","volume":"7","author":"Coffin","year":"2019","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jhepr.2022.100461_bib17","first-page":"905","article-title":"Lack of evidence of hepatitis D (delta) infection in Newfoundland and Labrador","volume":"134","author":"Ratnam","year":"1986","journal-title":"CMAJ"},{"key":"10.1016\/j.jhepr.2022.100461_bib18","first-page":"156","article-title":"The prevalence of antibody to delta virus in western Canada","volume":"9","author":"Cheng","year":"1986","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.jhepr.2022.100461_bib19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJM198601303140520","article-title":"Delta infection in Canada","volume":"314","author":"Parker","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2022.100461_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3138\/canlivj.2018-0008","article-title":"Management of hepatitis B virus infection: 2018 guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada","volume":"1","author":"Coffin","year":"2018","journal-title":"Can Liver J"},{"key":"10.1016\/j.jhepr.2022.100461_bib21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.14218\/JCTH.2015.00018","article-title":"Hepatitis B and delta virus: advances on studies about interactions between the two viruses and the infected hepatocyte","volume":"3","author":"Giersch","year":"2015","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jhepr.2022.100461_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jhepr.2022.100461_bib23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jgh3.12286","article-title":"Liver disease referrals to an urban, hospital-based hepatology outpatient clinic over the past 25 years","volume":"4","author":"Grubert Van Iderstine","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.jhepr.2022.100461_bib24","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/cid\/ciz271","article-title":"Hepatitis delta estimates in the United States revisited","volume":"69","author":"Soriano","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhepr.2022.100461_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2013.11.016","article-title":"Increasing prevalence of HDV\/HBV infection over 15 years in France","volume":"59","author":"Servant-Delmas","year":"2014","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jhepr.2022.100461_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcv.2015.02.011","article-title":"Hepatitis delta virus testing, epidemiology and management: a multicentre cross-sectional study of patients in London","volume":"66","author":"El Bouzidi","year":"2015","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jhepr.2022.100461_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12879-018-3008-x","article-title":"Characterization of hepatitis B and delta coinfection in Israel","volume":"18","author":"Shirazi","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jhepr.2022.100461_bib28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/liv.13604","article-title":"Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: the Hepatitis Delta International Network (HDIN)","volume":"38","author":"Wranke","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100461_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11904-020-00508-z","article-title":"Epidemiology, natural history, and treatment of hepatitis delta virus infection in HIV\/hepatitis B virus coinfection","volume":"17","author":"Ferrante","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jhepr.2022.100461_bib30","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/hep.31214","article-title":"Long-term study of hepatitis delta virus infection at secondary care centers: the impact of viremia on liver-related outcomes","volume":"72","author":"Kamal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2022.100461_bib31","article-title":"Demographics and outcomes of hepatitis B and D: a 10-year retrospective analysis in a Swiss tertiary referral center","volume":"16","author":"Barbosa","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100461_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/liv.14740","article-title":"Residual low HDV viraemia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: results from the HIDIT-II study","volume":"41","author":"Bremer","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100461_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jhep.2015.04.026","article-title":"Immigration and viral hepatitis","volume":"63","author":"Sharma","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100461_bib34","series-title":"Immigrant population by selected places of birth, admission category and period of immigration, Canada, provinces and territories, census metropolitan areas and areas outside of census metropolitan areas, 2016 Census","author":"Statistics Canada","year":"2017"},{"key":"10.1016\/j.jhepr.2022.100461_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cld.860","article-title":"Thrombocytopenia in cirrhosis: a review of pathophysiology and management options","volume":"14","author":"Moore","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2022.100461_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174453","article-title":"Prevalence and predictors for compensated advanced chronic liver disease (c-ACLD) in patients with chronic hepatitis delta virus (HDV) infection","volume":"12","author":"Couto","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2022.100461_bib37","doi-asserted-by":"crossref","first-page":"8184","DOI":"10.1038\/s41598-021-87679-w","article-title":"Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide\/nucleoside analogues","volume":"11","author":"Jang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2022.100461_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4269\/ajtmh.19-0688","article-title":"Noninvasive models for predicting liver fibrosis in individuals with hepatitis D virus\/hepatitis B virus coinfection in the Brazilian Amazon region","volume":"103","author":"Alves Vasconcelos","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jhepr.2022.100461_bib39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/liv.13205","article-title":"Non-invasive fibrosis score for hepatitis delta","volume":"37","author":"Lutterkort","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100461_bib40","doi-asserted-by":"crossref","first-page":"104691","DOI":"10.1016\/j.antiviral.2019.104691","article-title":"The delta-4 fibrosis score (D4FS): a novel fibrosis score in chronic hepatitis D","volume":"174","author":"Da","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhepr.2022.100461_bib41","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/liv.14043","article-title":"Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting","volume":"39","author":"Soc\u00edas","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2022.100461_bib42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.14745\/ccdr.v46i05a07","article-title":"National findings from the Tracks survey of people who inject drugs in Canada, phase 4, 2017\u20132019","volume":"46","author":"Tarasuk","year":"2020","journal-title":"CCDR"},{"key":"10.1016\/j.jhepr.2022.100461_bib43","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.9778\/cmajo.20170002","article-title":"Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort study","volume":"5","author":"Lau","year":"2020","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jhepr.2022.100461_bib44","doi-asserted-by":"crossref","first-page":"502","DOI":"10.17269\/s41997-020-00435-x","article-title":"Validating viral hepatitis B and C diagnosis codes: a retrospective analysis using Ontario\u2019s health administrative data","volume":"112","author":"Yasseen I","year":"2021","journal-title":"Can J Public Health"},{"key":"10.1016\/j.jhepr.2022.100461_bib45","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1053\/j.gastro.2006.01.035","article-title":"Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients","volume":"130","author":"Su","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2022.100461_bib46","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1099\/0022-1317-82-9-2183","article-title":"Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela","volume":"82","author":"Nakano","year":"2001","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jhepr.2022.100461_bib47","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1099\/vir.0.013615-0","article-title":"Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (labrea black fever) in the western Brazilian Amazon region","volume":"90","author":"Gomes-Gouvea","year":"2009","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jhepr.2022.100461_bib48","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jhep.2020.06.038","article-title":"Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta","volume":"73","author":"Roulot","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2022.100461_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.31055","article-title":"Economic and health care burdens of hepatitis delta: a study of commercially insured adults in the United States","volume":"72","author":"Elsaid","year":"2020","journal-title":"Hepatology"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555922000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T06:35:05Z","timestamp":1746858905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555922000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2589555922000337"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100461","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2022.100461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100461"}}